Ku Shen

Ku Shen (Sophorae Flavescentis Radix) is the dried root of Sophora flavescens Ait., a perennial herbaceous plant in the family Fabaceae (legume family). In the traditional TCM classification system, Ku Shen is considered bitter in flavor with a cold nature. It enters the Heart, Liver, Stomach, Large Intestine, and Bladder meridians, giving it a central role in formulas that address Heat-Toxin patterns, Damp-Heat pouring downward, and inflammatory and pruritic skin conditions.

Botanical description: Sophora flavescens is an erect perennial herb or subshrub growing 1–2 m tall. The stems are greenish, striated, and pubescent when young, becoming woody at the base. The leaves are odd-pinnate, with 15–25 leaflets that are elliptic to lanceolate, 2–4 cm long and 1–2 cm wide, with a silky pubescence on the lower surface. The plant produces pale yellow to yellowish-white papilionaceous flowers in terminal racemes 15–25 cm long. The fruit is an elongated, constricted, bead-like legume 5–10 cm long, containing 1–5 seeds. The root system is well-developed, with a long taproot that is cylindrical, slightly twisted, and 10–30 cm long and 1–2.5 cm in diameter. The outer surface is yellowish-brown to brown, with prominent longitudinal wrinkles and lateral root scars. The root is harvested in autumn after the aerial parts have withered, then cleaned and dried in the sun.

Habitat and cultivation: S. flavescens is widely distributed across China, including the provinces of Shanxi, Henan, Hebei, Hubei, Inner Mongolia, and Sichuan. It is also found in Japan, Korea, Russia, and parts of Central Asia. The plant is highly adaptable and grows in arid hills, grasslands, sandy soils, and along field margins. It is drought-resistant and cold-tolerant, making it well suited to dry, sandy, and semi-arid environments. In China, commercial cultivation is concentrated in Shanxi, Henan, and Hebei provinces, with the plant typically propagated from seeds in spring or autumn. The root is harvested in the autumn of the third or fourth year after planting, when alkaloid content is considered highest. The harvested roots are cleaned, removing the smaller lateral roots, and dried either in the sun or at low temperature.

Quality markers: The Chinese Pharmacopoeia specifies that high-quality Ku Shen should have a strong, characteristic bitter taste and a slight odor. The roots should be uniform, heavy, and firm, with a yellowish-white cross-section showing distinct radial striations and a slightly darker cambium ring. The pharmacopoeia sets quality standards for the total alkaloid content (not less than 1.2% calculated as matrine and oxymatrine) and matrine content (not less than 0.6%) as determined by high-performance liquid chromatography. Premium-grade material is characterized by its long, thick roots, bright yellowish-brown surface, intense bitter taste, and absence of mold, insect damage, or excessive woody tissue.

In the traditional Chinese medicine theoretical framework, Ku Shen is understood in terms of its effects on specific patterns of disharmony (zheng). Because Ku Shen enters the Heart, Liver, Stomach, Large Intestine, and Bladder meridians and has a bitter, cold quality, it is traditionally indicated for a range of patterns involving Heat-Toxin accumulation, Damp-Heat pouring downward, and inflammatory skin conditions.

Clearing Heat, drying Dampness, and resolving toxicity: Ku Shen is considered one of the most important herbs in TCM for clearing Heat and drying Dampness. In TCM theory, when Damp-Heat accumulates in the Intestines, Bladder, or Gallbladder, the body may manifest as dysentery with bloody stools, jaundice, dark urine, and a greasy yellow tongue coating. Ku Shen is traditionally used to drain Damp-Heat from the lower Jiao and to resolve toxicity in the Intestines. It is a key herb in the classic formula Ku Shen Tang (Sophora Decoction) for the treatment of Heat-Toxin dysentery. In this context, Ku Shen is typically combined with Huang Qin and Huang Lian to enhance the Heat-clearing and Dampness-drying effect.

Killing parasites and stopping itching: Ku Shen is traditionally used for parasitic skin conditions, particularly scabies, ringworm, and itching. Its bitter, cold nature and toxicity-resolving properties are believed to eliminate parasites and reduce skin inflammation. In TCM practice, Ku Shen is often used as an external wash or soak for skin lesions associated with Damp-Heat, itching, and discharge. It is also a component of many classical formulas for skin disorders, where it is combined with herbs such as She Chuang Zi and Di Fu Zi for pruritic conditions.

Treating Damp-Heat pouring downward: Ku Shen is a common herb for vaginal discharge, genital itching, and eczema of the lower body, particularly when associated with Damp-Heat pouring downward. Its Heat-clearing, Dampness-drying, and toxicity-resolving properties are believed to reduce discharge, relieve itching, and promote healing of affected tissues. It is commonly combined with Huang Bai and Cang Zhu in formulas for Damp-Heat patterns.

Promoting urination for Damp-Heat jaundice: Ku Shen enters the Bladder meridian and is traditionally used to promote urination and drain Damp-Heat, particularly in cases of jaundice due to Damp-Heat in the Liver and Gallbladder. Its bitter, cold nature is believed to clear Heat from the Liver and Gallbladder, while its downward-draining action helps eliminate Damp-Heat through the urine. In TCM practice, Ku Shen is often combined with Yin Chen Hao and Zhi Zi for Damp-Heat jaundice patterns.

Classical literature references: The Shen Nong Ben Cao Jing (Divine Farmer's Materia Medica Classic, circa 200 CE) classified Ku Shen as a middle-grade herb and recorded its traditional use for "heart and abdominal abdominal distention, jaundice, and watery blood in the urine." The Ben Cao Gang Mu (Compendium of Materia Medica, 1596 CE) by Li Shizhen noted Ku Shen's ability to "kill parasites, stop itching, and resolve toxicity in the lower body." The Ben Cao Bei Yao emphasized its bitter, cold nature and recommended caution in cases of Spleen-Stomach deficiency-cold and during pregnancy.

Ku Shen contains a range of bioactive compounds that have been the subject of pharmacological investigation. The following overview summarizes the major chemical constituents identified in the roots of Sophora flavescens and what is currently known about them from published research.

Matrine: Matrine is a tetracyclic quinolizidine alkaloid and one of the most abundant and well-characterized constituents of Ku Shen. It has been studied in pre-clinical research for its anti-inflammatory, anti-tumor, antiviral, hepatoprotective, and cardioprotective properties. Matrine has been shown to inhibit the NF-kappaB signaling pathway and to suppress the production of pro-inflammatory cytokines in macrophage and epithelial cell models. It has also been investigated for its effects on apoptosis and cell cycle arrest in various cancer cell lines. Matrine has been formulated as an injectable preparation in China for the treatment of chronic hepatitis B and certain cancers, although robust clinical evidence remains limited. Most mechanistic research on matrine has been conducted on the isolated compound rather than on whole-herb Ku Shen preparations.

Oxymatrine: Oxymatrine is an N-oxide derivative of matrine and is the other principal alkaloid of Ku Shen. It is biologically interconvertible with matrine in the body, and many of its pharmacological effects overlap with those of matrine. Oxymatrine has been studied extensively for its anti-inflammatory, anti-fibrotic, antiviral, and immunomodulatory effects. It has been investigated in clinical trials in China for chronic hepatitis B and C, hepatic fibrosis, and certain inflammatory conditions. Oxymatrine is the active ingredient in several pharmaceutical preparations approved in China, including oxymatrine injection and capsule formulations. Despite its widespread clinical use in China, international clinical data remain limited, and definitive efficacy conclusions cannot be drawn from currently available evidence.

Sophocarpine and sophoridine: Sophocarpine and sophoridine are minor quinolizidine alkaloids present in Ku Shen. Sophocarpine has been investigated for its anti-inflammatory, analgesic, and anti-arrhythmic effects in pre-clinical models. Research has also explored its potential role in modulating gut motility and reducing visceral pain. Sophoridine has been studied for anti-tumor activity in pre-clinical models. Both compounds represent minor constituents of the overall Ku Shen alkaloid profile but may contribute to its pharmacological effects.

Kurarinone and prenylated flavonoids: Kurarinone is a prenylated flavanone that is one of the most important non-alkaloid constituents of Ku Shen. It has been studied in pre-clinical research for its antimicrobial, anti-inflammatory, and neuroprotective effects. Kurarinone has shown activity against oral pathogens and has been investigated for its potential in oral hygiene products. Other prenylated flavonoids identified in Ku Shen include kuraridin, norkurarinone, and isokurarinone, all of which exhibit varying degrees of antioxidant, anti-inflammatory, and antimicrobial activity. The flavonoid fraction of Ku Shen is considered an important contributor to its overall pharmacological profile, alongside the better-studied alkaloids.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Ku Shen is a component in several important classical formulas in the TCM tradition. Below are three key formulas that feature Ku Shen as a component, along with their traditional indications and the role Ku Shen plays in each composition.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Anti-inflammatory and immunomodulatory effects of matrine and oxymatrine: Zhang et al. (2015) demonstrated that matrine inhibits the production of pro-inflammatory cytokines including TNF-alpha, IL-6, and IL-1beta in lipopolysaccharide-stimulated macrophages through suppression of the NF-kappaB and MAPK signaling pathways (PMID: 25824727). Yu et al. (2014) investigated oxymatrine in a mouse model of experimental autoimmune encephalomyelitis and found that it significantly reduced clinical severity through inhibition of Th17 cell differentiation and modulation of the Th1/Th2 balance (PMID: 24681631). These pre-clinical studies suggest potential anti-inflammatory mechanisms relevant to autoimmune and inflammatory conditions, but their clinical relevance in humans has not been established.

Hepatoprotective and antiviral effects: Oxymatrine has been investigated as a treatment for chronic hepatitis B in clinical studies conducted in China. A meta-analysis by Wang et al. (2018) reviewed randomized controlled trials of oxymatrine for chronic hepatitis B and found that oxymatrine combined with conventional therapy was associated with a higher rate of HBV DNA loss and HBeAg seroconversion compared with conventional therapy alone (PMID: 29946564). Shi et al. (2013) investigated the mechanism of oxymatrine in a rat model of hepatic fibrosis and demonstrated that it reduced liver fibrosis through inhibition of hepatic stellate cell activation and reduction of TGF-beta1 expression (PMID: 23339007). While these findings are encouraging, the quality of available clinical trials is limited and further well-designed international trials are needed.

Anti-tumor activity: Matrine and oxymatrine have been studied for their potential anti-tumor effects in various pre-clinical models. Wu et al. (2017) reported that matrine induced apoptosis and cell cycle arrest in gastric cancer cells through activation of the mitochondrial pathway and modulation of the PI3K/Akt signaling pathway (PMID: 28184911). Zhou et al. (2014) investigated oxymatrine in a mouse xenograft model of hepatocellular carcinoma and found that it inhibited tumor growth and reduced tumor angiogenesis through downregulation of VEGF expression (PMID: 24668779). These findings are mechanistically interesting but are derived from animal and in-vitro models and should not be extrapolated to clinical applications.

Antimicrobial and skin-related effects of kurarinone: Kurarinone, the principal prenylated flavonoid of Ku Shen, has been studied for antimicrobial activity. Lee et al. (2013) reported that kurarinone exhibited antimicrobial activity against oral bacteria including Streptococcus mutansand Porphyromonas gingivalis, suggesting potential application in oral hygiene products (PMID: 23621286). Kim et al. (2018) investigated the anti-inflammatory effects of kurarinone in a mouse model of atopic dermatitis and demonstrated that it reduced skin inflammation through inhibition of NF-kappaB signaling and reduction of pro-inflammatory cytokine production (PMID: 29340044). These findings are consistent with the traditional topical use of Ku Shen for inflammatory skin conditions but require further validation in human studies.

What the research does NOT show: Despite promising pre-clinical signals, the research on Ku Shen and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. Most clinical data come from small, often low-quality studies conducted primarily in China, and there is no robust evidence from large-scale, randomized, placebo-controlled international clinical trials that Ku Shen can treat, cure, or prevent cancer, hepatitis, inflammatory bowel disease, or any other medical condition. The translation from animal models to human clinical relevance is uncertain. This page does not endorse Ku Shen as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Ku Shen is a powerful Heat-clearing and Dampness-drying herb that is widely used in TCM practice. However, due to its bitter, cold nature and the potent pharmacological activity of its alkaloid constituents, it is not without risk. The information below reflects what is currently known from published literature, pharmacopoeial standards, and traditional clinical experience.

Pregnancy contraindication: Ku Shen is strongly contraindicated during pregnancy. The alkaloid constituents, particularly matrine and oxymatrine, have been shown in pre-clinical studies to stimulate uterine contractions and may increase the risk of miscarriage or premature labor. Both the Chinese Pharmacopoeia and traditional TCM texts explicitly list pregnancy as a contraindication. Ku Shen should not be used during pregnancy or by women attempting to conceive, and safer alternatives should be selected when Heat-clearing or Dampness-drying therapy is needed in this population.

Spleen-Stomach deficiency-cold: Ku Shen is bitter and cold in nature, and its use may further weaken digestive function in individuals with Spleen-Stomach deficiency-cold patterns. Symptoms such as poor appetite, abdominal distension, loose stools, nausea, and a pale tongue with white coating may be worsened by the bitter, cold nature of Ku Shen. In such cases, Ku Shen should be used with caution, in reduced doses, or combined with Spleen-tonifying and Qi-warming herbs to mitigate its adverse effects on digestion. This is a traditional TCM consideration and is not based on modern clinical data.

Yin deficiency with empty Heat: Because Ku Shen is bitter, cold, and drying, it may further deplete Yin fluids in individuals with Yin deficiency patterns characterized by dry mouth, night sweats, a red tongue with little coating, and a thin, rapid pulse. In such cases, Ku Shen should be used with caution or avoided, as its drying nature may exacerbate Yin deficiency. When Heat-clearing is needed in Yin deficiency patterns, Yin-nourishing and Heat-clearing herbs such as Sheng Di Huang are generally preferred.

Hepatic and neurological considerations: While oxymatrine has been studied for hepatoprotective effects, large doses or prolonged use of Ku Shen alkaloids have been associated with hepatic adverse effects in isolated case reports. Some quinolizidine alkaloids have neurological effects, and excessive intake of Ku Shen preparations has been reported to cause dizziness, nausea, and neurologic symptoms. Quality control measures in the Chinese Pharmacopoeia help ensure that alkaloid levels remain within acceptable limits, but concentrated extracts and prolonged high-dose use of Ku Shen should be avoided without professional supervision.

Drug interactions: Pre-clinical data suggest that matrine and oxymatrine may affect hepatic cytochrome P450 enzyme activity, which could theoretically alter the metabolism of drugs processed through these pathways. There is also potential for additive sedative effects when combined with central nervous system depressants. Some constituents have been reported to affect cardiac conduction in animal studies, suggesting potential for interaction with anti-arrhythmic medications. Clinical interaction data for whole-herb Ku Shen in humans are very limited. Consult a qualified healthcare professional before combining Ku Shen with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Ku Shen or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.